marijuana stocks

GW Pharmaceuticals Continues To Rally: A Technical Look

GW Pharmaceuticals Plc (NASDAQ:GWPH) shares were trading higher by $2.20 (2.5 percent) at $97.86 in Monday’s session. The darling of the marijuana sector is following through on Friday’s impressive nearly $11.00 rally ($84.58 to $95.66). It should be noted Friday’s rally took place on extremely high volume for the issue of nearly two million shares vs. its 20-day average of 325,000.

Investors may be anticipating positive results as the company is set to release additional Epidiolex data at the American Academy of Neurology that should inform developments in other orphan epilepsy. Over the past year, the issue has fluctuated primarily based on news concerning the drug and not so much on developments related to marijuana.

See Also: 15 Marijuana Stocks To Watch In 2015

After a bit off profit-taking off the open, it quickly found support just $0.16 from its opening price ($94.23 vs. $94.39) before ripping north once again. At time of writing, it easily surpassed Friday’s high ($95.92), reaching $98.43 before taking a breather.

The all-time high for the issue was made in July 2014, at the pinnacle of the “pot stock” mania at $111.46, before cascading to $58.16 in October.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

 Reliq Health Technologies Inc. (RQHTF) Signs Seven New Contracts in Texas

Reliq Health Technologies, Inc. Signs Seven New Contracts in Texas  Reliq Health…

$CANV Strategic Efforts to Mainstream Hemp-Derived CBD Oil Products

CannaVest’s Strategic Efforts to Mainstream Hemp-Derived CBD Oil Products Prove Successful in…

Tilray Brands, Inc. (TLRY) Launches New Cannabis Infused Cold Brew Teas

Solei Brand Launches New Cannabis Infused Cold Brew Teas Tilray Brands, Inc.…

Canopy Growth Corporation (CGC) Announces Refinancing of C$100 million of Notes due 2023

Canopy Growth Announces Refinancing of C$100 million of Notes due 2023 Canopy…